ARTICLE | Company News
Raptor, Horizon Pharma deal
October 31, 2016 7:00 AM UTC
Horizon completed its acquisition of Raptor for $9 per share in a cash deal (see BioCentury Sept. 19)....
Horizon completed its acquisition of Raptor for $9 per share in a cash deal (see BioCentury Sept. 19)....